Milestone Pharmaceuticals (MIST) Current Taxes (2018 - 2019)
Milestone Pharmaceuticals' (MIST) quarterly Current Taxes came in at $78000.0 in Q1 2019, up 39.29% quarter-over-quarter from $56000.0 in Q4 2018.
Powered by 
Analysis
Milestone Pharmaceuticals (MIST) Current Taxes (2018 - 2019) Analysis & Trends
Milestone Pharmaceuticals (MIST) has reported Current Taxes for 2 consecutive years, with $78000.0 the latest figure, recorded in Q1 2019.
- For the quarter ending Q1 2019, Current Taxes changed N/A year-over-year to $78000.0; the trailing twelve-month figure through Mar 2019 stood at $78000.0 (changed N/A YoY), and the FY2018 full-year result was $56000.0, changed N/A from the prior year.
- Current Taxes grew to $78000.0 in Q1 2019 per MIST's latest filing, from $56000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $78000.0 in Q1 2019 and bottomed at $56000.0 in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 49.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 86.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 74.18 Mn |
| 10 | Milestone Pharmaceuticals | 146.32 Mn | -25.18 Mn | - | - |